Indication
Xadago is indicated for the treatment of adult patients with idiopathic Parkinson’s disease (PD) as add-on therapy to a stable dose of Levodopa (L-dopa) alone or in combination with other PD medicinal products in mid-to late-stage fluctuating patients.
In other countries
The same active substances on other registers, the same brand first.
National listings
The national registers that list this EU medicine.
- XadagoBrazil · Zambon Laboratórios Farmacêuticos Ltda.Same brand
- Xadago 100 MG Comprimidos Recubiertos con PeliculaSpain · 100 mg · comprimido recubierto con película · Zambon S.P.A.Same brand
- Xadago 100 MG Comprimidos Recubiertos con PeliculaSpain · 100 mg · comprimido recubierto con película · Zambon S.P.A.